Magainin
Executive Summary
Former Bristol-Myers Squibb VP Zola Horovitz named chairman following resignation of Jay Moorin as chairman, president and CEO of biotech company. Magainin Senior VP and CFO Michael Dougherty succeeds Moorin as president and CEO. Former Exec VP and Director of the Magainin Institute of Molecular Medicine Roy Levitt, MD, is named to the newly created position of chief operating officer. Moorin will pursue other interests